Beranda › Hipertensi Arteri Pulmonal › Massachusetts
Uji klinis Hipertensi Arteri Pulmonal di Massachusetts
7 studi untuk Hipertensi Arteri Pulmonal mencari peserta di lokasi di Massachusetts.
Kota di Massachusetts
Teks studi resmi (Bahasa Inggris)
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
- Brigham and Women's Hospital ( Site 1014), Boston
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07218029Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
- Tufts Medical Center, Boston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07318597An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- Tufts Medical Center, Boston
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07365332A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- Tufts Medical Center, Boston
- Lahey Hospital and Medical Center, Burlington
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 21 Jul 2026 · NCT06649110A Prospective Longitudinal Observational Cohort Study of Pregnant Women Residing at High Altitude in Bolivia
- Massachusetts General Hospital, Boston
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 45 · Wanita · Diperbarui 26 Mei 2026 · NCT07312227Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Brigham and Women's Hospital, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2025 · NCT04555161Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
- Boston Children's Hospital, Boston
Menerima pesertaStudi observasional
1 Day – 21 Years · Semua jenis kelamin · Diperbarui 13 Mar 2025 · NCT02249923Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.